Katalyst.Ventures, a San Francisco-based venture fund established in 2017, focuses on Seed, Series A, and Series B stages. With a portfolio concentrating on BioTech, Healthcare, and Pharmaceuticals, the fund has invested in 29 companies and achieved 2 exits. Partnered by Jeannine Sargent, Katalyst.Ventures collaborates with innovators in digital health, fintech, and enterprise SaaS sectors. One of their portfolio companies is Arine. For more information, visit their website or reach out to Jeannine via email.